Description
GLOW research focuses on the stimulation of the melanocortin system to enhance the skin’s natural aesthetic and protective qualities. As a synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH), it primarily targets the MC1 receptors located on melanocytes. In research settings, these compounds are studied for their ability to induce systemic tanning without the requirement for harmful UV radiation exposure. This mechanism is investigated not only for cosmetic symmetry but also for its potential to provide photoprotection to individuals with light-sensitive skin types or erythropoietic protoporphyria.
- Uniform Pigmentation: Research indicates the peptide promotes an even distribution of melanin throughout the epidermis.
- Photoprotection: Studies suggest that increased eumelanin density acts as a biological shield against DNA damage caused by UV rays.
- Skin Texture: Preliminary data shows improvements in skin hydration and a reduction in the appearance of fine lines through melanocortin signaling.
- Antioxidant Support: Investigations have observed a decrease in lipid peroxidation and inflammatory markers within the skin tissue.
Reviews
There are no reviews yet.